Dynavax Technologies Corporation

(NASDAQ:DVAX)

0.25

0.00 (0.00%)

Dec 03 - Close

Open
0.25
High
0.26
Low
0.23
Vol.
168.66K
Mkt Cap
9.96M
52Wk High
6.55
52Wk Low
0.15
Avg. Vol.
341.20K
P/E (Trailing)
-0.27
Beta
0.76
Short %
1.00%
Div. Yield
—

After-Hours 0.26 +0.01 (4.00%) Wed, 3 Dec 2008 3:58 PM

Company Profile

Dynavax Technologies Corporation

2929 Seventh Street

Berkeley, CA 94710-2753

United States - Map

Phone: (510) 848-5100

Fax: (510) 848-5694

Website: www.dynavax.com

State of incorporation: Delaware

CEO: Dr. Dino Dina, M.D.

Employees: 173

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Engage in commercialize innovative products

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

Recent news for DVAX

Recent opinions on DVAX

No recent Opinions for DVAX

No members own DVAX

Member sentiment: Neutral